ENDRA Life Sciences Inc. (NDRA) NASDAQ

6.43

+0.2989(+4.88%)

Updated at October 20 11:10AM

Currency In USD

Valuation

Market Cap7.03M
Enterprise Value4.38M
P/E Ratio-0.5
PEG Ratio0.16
Price/Sales Ratio21.81
Price/Book Ratio2.98
Enterprise/Revenue15.89
Enterprise/EBITDA-0.42

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-41.42
Operating Margin-40.53

Management Effectiveness

Return On Assets-3.12
Return On Equity-2.83

Income Statement

Revenue0
Revenue/Share0.3
Gross Profit-206,172
EBITDA-11.3M
Net Income-11.51M
Diluted EPS-10.25

Balance Sheet

Total Cash1.81M
Total Cash/Share2.52
Total Debt557,492
Total Debt/Equity0.38
Current Ratio3.21
Book Value Per Share2.05

Price History

52-Week Change-20.8
52-Week High22.68
52-Week Low2.9
Moving Average 50 Days5.07
Moving Average 200 Days4.77

Statistics

Average Volume275,856
Shares Outstanding752,755
% Held by Institutions0.01

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:35
Last Split DateNovember 07, 2024